Filter News
Area of Research
- (-) Nuclear Science and Technology (25)
- Advanced Manufacturing (1)
- Biology and Environment (10)
- Clean Energy (40)
- Climate and Environmental Systems (2)
- Computer Science (2)
- Energy Sciences (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (4)
- Fusion Energy (4)
- Isotopes (3)
- Materials (48)
- Materials for Computing (4)
- National Security (7)
- Neutron Science (14)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (3)
- Supercomputing (39)
News Topics
- (-) Computer Science (2)
- (-) Cybersecurity (1)
- (-) Isotopes (5)
- (-) Materials Science (2)
- (-) Nuclear Energy (22)
- (-) Space Exploration (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (8)
- Bioenergy (1)
- Biomedical (2)
- Coronavirus (1)
- Decarbonization (1)
- Environment (1)
- Fusion (6)
- Molten Salt (4)
- Neutron Science (4)
- Physics (1)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.